Molecular characterization of Burkitt lymphoma in the breast or ovary.

Burkitt Lymphoma / diagnosis Female Humans In Situ Hybridization, Fluorescence Lymphoma / genetics Lymphoma, Large B-Cell, Diffuse / genetics Ovary Translocation, Genetic
Burkitt MYC Ovary breast lymphoma

Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
09 2021
Historique:
pubmed: 25 6 2021
medline: 25 2 2023
entrez: 24 6 2021
Statut: ppublish

Résumé

Breast and ovary have been described as rare but typical sites of presentation of Burkitt lymphoma (BL) in females, particularly after puberty. We revised a historic series of 44 lymphomas of the breast or the ovary in women diagnosed between 1973 and 2014 as BL. Fluorescence

Identifiants

DOI: 10.1080/10428194.2021.1907374 PMID: 34165048
pubmed: 34165048
doi: 10.1080/10428194.2021.1907374
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2120-2129

Auteurs

Shaymaa Elgaafary (S)

Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
Institute of Human Genetics, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Department of Human Cytogenetics, National Research centre, Division of Human Genetics and Genome Research, Cairo, Egypt.
ORCID: 0000-0002-2846-6000

Cristina López (C)

Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
Institute of Human Genetics, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
ORCID: 0000-0001-6644-1659

Inga Nagel (I)

Institute of Human Genetics, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Institute of Experimental and Clinical Pharmacology, Christian-Albrechts University Kiel and University, Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Inga Vater (I)

Institute of Human Genetics, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Susanne Bens (S)

Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
Institute of Human Genetics, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Monika Szczepanowski (M)

Hematopathology Section and Lymph Node Registry, Christian-Albrechts University Kiel and University Hospital, Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Clinic of Internal Medicine II, Laboratory of Hematology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Sietse M Aukema (SM)

Institute of Human Genetics, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Hematopathology Section and Lymph Node Registry, Christian-Albrechts University Kiel and University Hospital, Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Rabea Wagener (R)

Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
Institute of Human Genetics, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Lydia Hopp (L)

Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.

Hans Binder (H)

Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.

Laurence de Leval (L)

Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.

Wolfram Klapper (W)

Hematopathology Section and Lymph Node Registry, Christian-Albrechts University Kiel and University Hospital, Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Reiner Siebert (R)

Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
Institute of Human Genetics, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Lymphome malin non hodgkinien › Lymphome B › Lymphome de Burkitt › Molecular characterization of Burkitt lymphoma...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Molecular characterization of Burkitt lymphoma...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Hybridation in situ › Hybridation fluorescente in situ › Molecular characterization of Burkitt lymphoma...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Molecular characterization of Burkitt lymphoma...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Lymphome malin non hodgkinien › Lymphome B › Lymphome B diffus à grandes cellules › Molecular characterization of Burkitt lymphoma...
questionsmedicales.fr › Système endocrine › Glandes endocrines › Gonades › Ovaire › Molecular characterization of Burkitt lymphoma...
questionsmedicales.fr › Phénomènes génétiques › Mutagenèse › Translocation génétique › Molecular characterization of Burkitt lymphoma...